Storys aus Switzerland

13.10.2011 – 14:16
The International Osteoporosis Foundation (IOF)
Three Steps to Unbreakable Bones on World Osteoporosis Day
Nyon, Switzerland (ots) - For this year's World Osteoporosis Day (October 20), the International Osteoporosis Foundation (IOF) is releasing a 24-page report promoting a three-step strategy for healthy bones and strong muscles. To view the Multimedia News Release (MNR), please click: http://multivu.prnewswire.com/mnr/prne/iof/52143/ Professor Heike Bischoff-Ferrari, director Centre on Aging and Mobility at the University ...
mehr
11.10.2011 – 12:00
Pevion Biotech AG
Pevion's therapeutic Candida vaccine shows robust systemic and mucosal immunogenicity, while epidemiological survey confirms excellent market potential
Ittigen/Bern, Switzerland (ots) - Pevion Biotech AG today announced latest results from the ongoing clinical study of its therapeutic Candida vaccine PEV7, showing high levels of specific antibodies and a 100% mucosal immune response rate. The announcement further included the results of the largest, international ...
mehr
11.10.2011 – 09:00
Earth Council Geneva
Earth Council Geneva nominates Dr. Giovanni Eduardo Picone as a new board member
Geneva, Switzerland (ots) - Earth Council Geneva (ECG) is proud to announce that Dr. Giovanni Eduardo Picone is joining its ranks as a new Board member, working with other distinguished members such as Musaed Al Saleh, Lucas Assunçao, José-Maria Figueres, Christine Novakovic, Mohammed Sahnoun, Paul Stern and Chairman Reto Braun. Giovanni Picone comes from an ...
mehr
06.10.2011 – 09:00
Synova S.A.
Synova S.A. attracts CHF 20m in growth capital from HPE
Ecublens, Switzerland / Amsterdam, the Netherlands (ots) - Holland Private Equity ("HPE") invested substantial primary capital in Synova S.A. ("Synova") in a capital increase of up to CHF 20 million to become its largest outside shareholder. The expansion capital will allow Synova to further execute its internationalization, sales expansion and fuel further product development of its unique water-jet guided laser cutting ...
mehr
06.10.2011 – 08:50
sicap AG
Sicap and T-Hrvatski Telekom extend Device Management to Crnogorski Telekom
Bern, Switzerland (ots) - Long term partners, sicap and telecom services company T-Hrvatski Telekom, have extended the reach of the sicap Device Management Centre (http://www.sicap.com/en/Device_Management_Centre.58.0.html) (DMC) to serve mobile customers of Crnogorski Telekom in Montenegro, the second operator of the group whose customers benefit from the DMC ...
mehr
04.10.2011 – 08:00
Roche Professional Diagnostics
Roche and Diagnostica Stago terminate partnership
Rotkreuz, Switzerland/Asnieres, France (ots) - Roche Professional Diagnostics and Diagnostica Stago announced today that the companies have decided to pursue separate paths in the business of Laboratory Coagulation in the territories where Roche distributed the Stago product range. The exclusive sales of Stago products by Roche will continue throughout the entire year of 2011. With the exception of Japan where Roche ...
mehr
30.09.2011 – 14:00
Graubünden Ferien
A Small Mountain Village Gets Big on Facebook / Now anybody can "become" Swiss
Chur, Switzerland (ots) - The little mountain village of Obermutten in Graubünden has been on Facebook for a few days and is making an unusual promise. Anyone who goes to www.facebook.com/obermutten and clicks on "like" can put his/her photo onto the Commune's official notice board. By doing this, anybody anywhere in the world can "become Swiss". After only three ...
mehr
27.09.2011 – 02:30
ForaCare Suisse AG
ForaCare Suisse AG launches Bluetooth enabled Single-Device Smart Diabetes, BP Monitors
St. Gallen, Switzerland (ots) - ForaCare Suisse AG located in St. Gallen, Switzerland announced today the launch of a Bluetooth enabled innovative, smart single-unit devices for combined blood glucose and blood pressure (BP) monitoring. One device, the Comfort Pro GD 40, is approved for use by medical professionals and the other, Duo Ultima D40b, is being made ...
mehr
23.09.2011 – 12:00
Helsinn Healthcare SA
Helsinn Group and Eisai Inc. announce start of phase III clinical program of oral fixed-dose combination of Netupitant/Palonosetron (300mg/0.50mg) for prevention of CINV
Lugano, Switzerland and Woodcliff Lake, NJ, USA (ots) - Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and ...
mehr

Vorherige78910111213141516